Breast carcinoma is heterogeneous disease. Understanding the process of invasion and metastasis and the selection of the therapy for patients with breast carcinomas still remains difficult. MicroRNAs are powerful gene expression regulators. Because of inconsistent findings, we have analyzed potential difference in miR-155 levels in three breast cancer groups.
OBJECTIVES:
Our goals were to examine miR-155 expression levels in normal tissue, non-invasive and invasive breast carcinomas, and their association with standard clinical and pathological parameters and oncomiR-21, and to investigate the ability of miR-155 to separate invasive breast carcinomas with non-invasive component from pure invasive.
METHODS:
In the group of 40 breast tissue samples, relative expression levels of miR-155 were examined with stem-loop quantitative real-time PCR using TaqMan technology.
RESULTS:
The significant difference among four examined groups of the breast tissue was detected (p = 0.001). In the group of pure invasive tumors, patients with positive nodal status had significantly higher miR-155 levels (p = 0.046).
CONCLUSION:
Our results suggest that miR-155 might be involved in breast cancer pathogenesis and in tumor spreading to the lymph nodes, and that it might be used as biomarker for additional stratification of patients with invasive breast carcinomas with non-invasive component.
AltuviaY., LandgrafP., LithwickG., ElefantN., PfefferS., AravinA., et al., Clustering and conservation patterns of human microRNAs, Nucleic Acids Research33 (2005), 2697-2706.
2.
BlenkironC., GoldsteinL.D., ThorneN.P., SpiteriI., ChinS.-F., DunningM.J., et al., MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype, Genome Biology8 (2007), R214-R214.
3.
CascioneL., GaspariniP., LovatF., CarasiS., PulvirentiA., FerroA., et al., Integrated MicroRNA and mRNA Signatures Associated with Survival in Triple Negative Breast Cancer, PLoS ONE8 (2013), e55910.
4.
ChenJ., WangB.-C., TangJ.-H., Clinical significance of MicoRNA-155 expression in human breast cancer, Journal of Surgical Oncology106 (2012), 260-266.
5.
ChiavarinaB., Whitaker-MenezesD., MignecoG., Martinez-OutschoornU.E., PavlidesS., HowellA., et al., HIF1-alpha functions as a tumor promoter in cancer-associated fibroblasts, and as a tumor suppressor in breast cancer cells, Cell Cycle9 (2014), 3534-3551.
6.
GaspariniP., LovatF., FassanM., CasadeiL., CascioneL., JacobN.K., et al., Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation, Proceedings of the National Academy of Sciences111 (2014), 4536-4541.
7.
ZhengS.R., GuoG-L., ZhangW., HuangG-L., HuX-Q., ZhuJ., HuangQ-D., et al., Clinical significance of miR-155 expression in breast cancer and effects of miR-155 ASO on cell viability and apoptosis, Oncology Reports27 (2012), 1149-1155.
8.
HabbeN., KoorstraJ.B., MendellJ.T., OfferhausG.J., RyuJ.K., FeldmannG., et al., MicroRNA miR-155 is a biomarker of early pancreatic neoplasia, Cancer Biology and Therapy8 (2009), 340-346.
9.
HuS., ZhuW., ZhangL.-F., PeiM., LiuM.-F., MicroRNA-155 broadly orchestrates inflammation-induced changes of microRNA expression in breast cancer, Cell Research24 (2013), 254-257.
10.
HuangT.H., WuF., LoebG.B., HsuR., HeidersbachA., BrincatA., et al., Up-regulation of miR-21 by HER2/neu Signaling Promotes Cell Invasion, Journal of Biological Chemistry284 (2009), 18515-18524.
11.
IorioM.V., MicroRNA Gene Expression Deregulation in Human Breast Cancer, Cancer Research65 (2005), 7065-7070.
12.
IorioM.V., FerracinM., LiuC.G., VeroneseA., SpizzoR., SabbioniS., et al., MicroRNA gene expression deregulation in human breast cancer, Cancer Research65 (2005), 7065-7070.
13.
JiangS., ZhangH.W., LuM.H., HeX.H., LiY., GuH., et al., MicroRNA-155 Functions as an OncomiR in Breast Cancer by Targeting the Suppressor of Cytokine Signaling 1 Gene, Cancer Research70 (2010), 3119-3127.
14.
JohanssonJ., BergT., KurzejamskaE., PangM.F., TaborV., JanssonM., et al., MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer, Oncogene32 (2013), 5614-5624.
15.
KongW., HeL., CoppolaM., GuoJ., EspositoN.N., CoppolaD., et al., MicroRNA-155 Regulates Cell Survival, Growth, and Chemosensitivity by Targeting FOXO3a in Breast Cancer, Journal of Biological Chemistry285 (2010), 17869-17879.
16.
KongW., YangH., HeL., ZhaoJ.J., CoppolaD., DaltonW.S., et al., MicroRNA-155 Is Regulated by the Transforming Growth Factor/Smad Pathway and Contributes to Epithelial Cell Plasticity by Targeting RhoA, Molecular and Cellular Biology28 (2008), 6773-6784.
17.
KongW., HeL., RichardsE.J., ChallaS., XuC.X., Permuth-WeyJ., et al., Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer, Oncogene33 (2013), 679-689.
18.
LeeY.S., DuttaA., MicroRNAs in cancer, Annual review of pathology4 (2009), 199-227.
19.
LiuZ., miR-155 and miR-31 are differentially expressed in breast cancer patients and are correlated with the estrogen receptor and progesterone receptor status, Oncology Letters (2012).
20.
MattiskeS., SuetaniR.J., NeilsenP.M., CallenD.F., The Oncogenic Role of miR-155 in Breast Cancer, Cancer Epidemiology Biomarkers & Prevention21 (2012), 1236-1243.
21.
PetrovićN., MandušićV., StanojevićB., LukićS., TodorovićL., RoganovićJ., et al., The difference in miR-21 expression levels between invasive and non-invasive breast cancers emphasizes its role in breast cancer invasion, Medical Oncology31 (2014).
22.
PolyakK., Heterogeneity in breast cancer, Journal of Clinical Investigation121 (2011), 3786-3788.
23.
PolyakK., Breast cancer: origins and evolution, Journal of Clinical Investigation117 (2007), 3155-3163.
24.
QiL., BartJ., TanL., PlatteelI., SluisT., HuitemaS., et al., Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma, BMC Cancer9 (2009), 163.
25.
QianB., KatsarosD., LuL., PretiM., DurandoA., ArisioR., et al., High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-β 1, Breast Cancer Research and Treatment117 (2008), 131-140.
26.
RaskL., BalslevE.V.A., JØRgensenS., EriksenJ., FlygerH., MØLlerS., et al., High expression of miR-21 in tumor stroma correlates with increased cancer cell proliferation in human breast cancer, Apmis119 (2011), 663-673.
27.
TiliE., CroceC.M., MichailleJ.-J., miR-155: On the Crosstalk Between Inflammation and Cancer, International Reviews of Immunology28 (2009), 264-284.
28.
Valinezhad OrangA., SafaralizadehR., Kazemzadeh-BaviliM., Mechanisms of miRNA-Mediated Gene Regulation from Common Downregulation to mRNA-Specific Upregulation, International Journal of Genomics2014 (2014), 1-15.
29.
WangL., HouY., SunY., ZhaoL., TangX., HuP., et al., c-Ski activates cancer-associated fibroblasts to regulate breast cancer cell invasion, Molecular Oncology7 (2013), 1116-1128.
30.
YanaiharaN., CaplenN., BowmanE., MasahiroS., KensukeK., MingY., et al., Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell9 (2006), 189-198.
31.
YanL.X., HuangX.F., ShaoQ., HuangM.Y., DengL., WuQ.L., et al., MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis, Rna14 (2008), 2348-2360.
32.
YanL.X., WuQ.N., ZhangY., LiY.Y., LiaoD.Z., HouJ.H., et al., Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth, Breast Cancer Research13 (2011), R2.
33.
ZhangB., PanX., CobbG.P., AndersonT.A., microRNAs as oncogenes and tumor suppressors, Developmental Biology302 (2007), 1-12.
34.
ZhangH.X., XiaoH.P., TianZ.L., LiuS.S., XiaT.Z., Upregulation of microRNA-155 promotes the migration and invasion of colorectal cancer cells through the regulation of claudin-1 expression, International Journal of Molecular Medicine (2013).
35.
ZhuW., QinW., AtasoyU., SauterE.R., Circulating microRNAs in breast cancer and healthy subjects, BMC Research Notes2 (2009), 89.
